............................................................................................................. this blog is started in a simple attempt to discuss and spread knowlege regarding respiratory, critical care and sleep medicine related disorders ....this will bring doctors together in same plateform .....................................
Search This Blog
Pages
translate
Sunday, December 27, 2009
quiz of month
when he noted that his exercise tolerance had decreased as a result of shortness of breath. He denies fevers, chills, weight loss, or medication noncompliance. The patient does have an occasional dry cough. His current medications include immune supressant, trimethoprim-sulfamethoxazole (TMP-SMX), pantoprazole, diltiazem, and mycophenolate mofetil. He has past history of tobacco use. Physical examination show dry crackles on the side of the origin lung and decreased breath sounds on the side of the transplanted lung. Review of pulmonary function testing shows an FEV1/FVC ratio of 55% of the predicted value and an FEV1 of 0.90 L. Additionally, FEV1 has fallen by 31% progressively over the last 1-1/2 year. Which of the following can ameliorate the fall in FEV1 in this patient?
A. Augmented immunosuppression
B. Reduced immunosuppression
C. Antifungal therapy
D. Antiviral therapy
E. Administration of α1 antitrypsin
F. None of the above
Variants of DENND1B Associated with Asthma in Children
Background Asthma is a complex disease that has genetic and environmental causes. The genetic factors associated with susceptibility to asthma remain largely unknown.
Methods We carried out a genomewide association study involving children with asthma. The sample included 793 North American children of European ancestry with persistent asthma who required daily inhaled glucocorticoid therapy and 1988 matched controls (the discovery set). We also tested for genomewide association in an independent cohort of 917 persons of European ancestry who had asthma and 1546 matched controls (the replication set). Finally, we tested for an association between 20 single-nucleotide polymorphisms (SNPs) at chromosome 1q31 and asthma in 1667 North American children of African ancestry who had asthma and 2045 ancestrally matched controls.
Results In our meta-analysis of all samples from persons of European ancestry, we observed an association, with genomewide significance, between asthma and SNPs at the previously reported locus on 17q21 and an additional eight SNPs at a novel locus on 1q31. The SNP most strongly associated with asthma was rs2786098 (P=8.55x10–9). We observed replication of the association of asthma with SNP rs2786098 in the independent series of persons of European ancestry (combined P=9.3x10–11). The alternative allele of each of the eight SNPs on chromosome 1q31 was strongly associated with asthma in the children of African ancestry (P=1.6x10–13 for the comparison across all samples). The 1q31 locus contains DENND1B, a gene that is expressed by natural killer cells and dendritic cells and that encodes a protein that interacts with the tumor necrosis factor receptor.
Conclusions We have identified a locus containing DENND1B on chromosome 1q31.3 that is associated with susceptibility to asthma.Tuesday, November 24, 2009
DNB Final Examination (RESPIRATORY DISEASES) Previous Years Question Papers
http://natboard.edu.in/notice_for_dnb_candidates/RESPIRATORY%20DISEASES.pdf
The Sequential Organ Failure Assessment (SOFA) Score
The SOFA system was created in a consensus meeting of the European Society of Intensive Care Medicine in 1994 and further revised in 1996. The SOFA is a six-organ dysfunction/failure score measuring multiple organ failure daily. Each organ is graded from 0 (normal) to 4 (the most abnormal), providing a daily score of 0 to 24 points. The objective in the development of the SOFA was to create a simple, reliable, and continuous score easily obtained in every institution.
Sequential assessment of organ dysfunction during the first few days of ICU admission is a good indicator of prognosis. Both the mean and highest SOFA scores are particularly useful predictors of outcome. Independent of the initial score, an increase in SOFA score during the first 48 hours in the ICU predicts a mortality rate of at least 50%.
Sunday, November 8, 2009
FOUR Score for Comatose Patients
Eye response
4 = eyelids open or opened, tracking, or blinking to command
3 = eyelids open but not tracking
2 = eyelids closed but open to loud voice
1 = eyelids closed but open to pain
0 = eyelids remain closed with pain
Motor response
4 = thumbs-up, fist, or peace sign
3 = localizing to pain
2 = flexion response to pain
1 = extension response to pain
0 = no response to pain or generalized myoclonus status
Brainstem reflexes
4 = pupil and corneal reflexes present
3 = one pupil wide and fixed
2 = pupil or corneal reflexes absent
1 = pupil and corneal reflexes absent
0 = absent pupil, corneal, and cough reflex
Respiration
4 = not intubated, regular breathing pattern
3 = not intubated, Cheyne–Stokes breathing pattern
2 = not intubated, irregular breathing
1 = breathes above ventilator rate
0 = breathes at ventilator rate or apnea
FOUR = Full Outline of UnResponsiveness.
Thursday, October 29, 2009
Respiratory examination video link
http://www.youtube.com/watch?v=hWGzi5h2UR8&feature=player_embedded
this will be useful for young doctors
Wednesday, October 28, 2009
imprtant journals for respiratory critical care and sleep
Chest
Eroupean respiratory journal
Thorax
Current opinion in respiratory medicine
Critical care medicne
Indian journal of sleep medicine
Sleep medicine
link will be post soon
Sunday, October 25, 2009
Respiratory Medicine in India in the 21st Century
Saturday, October 24, 2009
welcome
COOSMIC SLEEP LAB
COOSMIC SLEEP LAB PROVIDE ALL TYPE OF SOLUTION TO YOU SLEEP PROBLEMS IN GENERAL AND SLEEP APNEA IN PARTICULAR IN GUWAHATI AND NORTH EAST REGION OF INDIA, MOSTLY FOCUS ON HOME BASED SLEEP STUDY TEST
CONTACT
08811095389
email- coosmicsleeplab@gmail.com
welcome and disclaimer
DISCLAIMER:
Information provided here is for medical education only. It is not intended as and does not substitute for medical advice. If you are a patient, please see your doctor for evaluation of your individual case. The web site should not be used as a substitute for competent medical advice from a licensed physician. By accessing the web site, the visitors acknowledge that there is no physician-patient relationship between them and the author. Under no circumstances will the author be liable to you for any direct or indirect damages arising in connection with use of this website.
The appearance of external hyperlinks to other websites does not constitute endorsement. The author does not verify, endorse, or take responsibility for the accuracy, currency, completeness or quality of the content contained in these sites.